Working… Menu

Telmisartan for Treatment of COVID-19 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04355936
Recruitment Status : Completed
First Posted : April 21, 2020
Last Update Posted : December 24, 2020
Carlos R. Rojo, MD
Facultad de Medicina, Universidad de Buenos Aires, UBA
Information provided by (Responsible Party):
Laboratorio Elea Phoenix S.A.